Interleukin-4 induces the activation and collagen production of cultured human intrahepatic fibroblasts via the STAT-6 pathway

Laboratory Investigation

Volumn 88, Issue 9, 2008, Pages 973-985

  Aoudjehane, Lynda ^a   Pissaia Jr , Alcindo ^a   Scatton, Olivier ^b   Podevin, Philippe ^a   Massault, Pierre Philippe ^b   Chouzenoux, Sandrine ^a   Soubrane, Olivier ^b   Calmus, Yvon ^a,b   Conti, Filomena ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b AP HP ^*  (France)

Author keywords

Collagen; Fibrosis; Human intrahepatic fibroblasts; IL 4; Liver transplantation and STAT 6

Indexed keywords

COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; COLLAGEN TYPE 4; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; SMALL INTERFERING RNA; STAT6 PROTEIN;

ARTICLE; CELL ACTIVATION; CELL CULTURE; CELL ISOLATION; CONTROLLED STUDY; FIBROBLAST; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION;

CELLS, CULTURED; COLLAGEN; FIBROBLASTS; HUMANS; INTERLEUKIN-4; LIVER; RNA, MESSENGER; RNA, SMALL INTERFERING; STAT6 TRANSCRIPTION FACTOR;

EID: 50249121141     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2008.61     Document Type: Article

References (69)

1. Kisseleva T, Brenner DA. Hepatic stellate cells and the reversal of fibrosis. J Gastroenterol Hepatol 2006;21:84-87.
2. Iredale JP. Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ. J Clin Invest 2007;117:539-548.
3. Iredale JP. Hepatic stellate cell behavior during resolution of liver injury. Semin Liver Dis 2001;21:427-436.
4. Bataller R. Liver fibrosis. J Clin Invest 2005;115:209-218.
5. Gressner AM. Proliferation and transformation of cultured liver fat-storing cells perisinusoidal lipocytes under conditions of β-D-xyloside-induced abrogation of proteoglycan synthesis. Exp Mol Pathol 1991;55:143-169.
6. Sato J, Schorey J, Ploplis VA, et al. The fibrinolytic system in dissemination and matrix protein deposition during a mycobacterium infection. Am J Pathol 2003;163:517-531.
7. Lotersztajn S, Julien B, Teixeira CF, et al. HEPATIC FIBROSIS: molecular mechanisms and drug targets. Annu Rev Pharmacol Toxicol 2005;45:605-628.
8. Knittel T, Kobold D, Piscaglia F, et al. Localization of liver myofibroblasts and hepatic stellate cells in normal and diseased rat livers: distinct roles of (myo-)fibroblast subpopulations in hepatic tissue repair. Histochem Cell Biol 1999;112:387-401.
9. Kinnman N, Francoz C, Barbu V, et al. The myofibroblastic conversion of peribiliary fibrogenic cells distinct from hepatic stellate cells is stimulated by platelet-derived growth factor during liver fibrogenesis. Lab Invest 2003;83:163-173.
10. Friedman SL. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 2000;275:2247-2250.
11. Nagy P, Schaff Z, Lapis K. Immunohistochemical detection of transforming growth factor-beta 1 in fibrotic liver diseases. Hepatol 1991;14:269-273.
12. Castilla A, Prieto J, Fausto N. Transforming growth factors beta 1 and alpha in chronic liver disease. Effects of interferon alfa therapy. N Engl J Med 1991;324:933-940.
13. Shimoda M, Ghobrial RM, Carmody IC, et al. Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C. Liver Transpl 2004;10:1478-1486.
14. Kornberg A, Kqpper B, Tannapfel A, et al. Impact of mycophenolate mofetil vs azathioprine on early recurrence of hepatitis C after liver transplantation. Int Immunopharmacol 2005;5:107-115.
15. Feray C. Fibrosis progression after liver transplantation in patients with recurrent hepatitis. J of Hepatol 2004;41:862-863.
16. Curry MP. Hepatitis B and Hepatitis C viruses in liver transplantation. Transplantation 2004;78:955-963.
17. Berenguer M, Lopez-Labrador FX, Wright TL. Hepatitis C and liver transplantation. J Hepatol 2001;35:666-678.
18. Schirren CA, Jung MC, Gerlach JT, et al. Liver-derived hepatitis C virus (HCV)-specific CD41 T cells recognize multiple HCV epitopes and produce interferon gamma. Hepatol 2000;32:597-603.
19. Zekry A, Bishop GA, Bowen DG, et al. Intrahepatic cytokine profiles associated with posttransplantation hepatitis C virus-related liver injury. Liver Transpl 2002;8:292-301.
20. Boleslawski E, Conti F, Sanquer S, et al. Defective inhibition of peripheral CD8+ T cell IL-2 production by anti-calcineurin drugs during acute liver allograft rejection. Transplantation 2004;77:1815-1820.
21. Conti F, Calmus Y, Rouer E, et al. Increased expression and role of interleukin-4 during liver allograft rejection. J Hepatol 1999;30:935-943.
22. Dharancy S, Podevin P, Aoudjehane L, et al. Elevated interleukin-4 expression in severe recurrent hepatitis C virus after liver transplantation. Transplantation 2007;83:906-911.
23. Kim J, Cheon IS, Won YJ, et al. IL-4 inhibits cell cycle progression of human umbilical vein endothelial cells by affecting p53, p21Waf1, cyclin D1, and cyclin E expression. Mol Cells 2003;16:92-96.
24. Vella V, Mineo R, Frasca F, et al. Interleukin-4 stimulates papillary thyroid cancer cell survival: implications in patients with thyroid cancer and concomitant Graves' disease. J Clin Endocrinol Metab 2004;89:2880-2889.
25. Nelms K, Keegan AD, Zamorano J, et al. The IL-4 receptor: signaling mechanisms and biologic functions. Annu Rev Immunology 1999;17:701-738.
26. Sempowski GD, Beckmann MP, Derdak S, et al. Subsets of murine lung fibroblasts express receptors membrane-bound and soluble IL-4: role of IL-4 in enhancing fibroblast proliferation and collagen synthesis. J Immunol 1994;152:3606-3614.
27. Doucet C, Brouty-Boye D, Pottin-Clemenceau C, et al. IL-4 and IL-13 specifically increase adhesion molecule and inflammatory cytokine expression in human lung fibroblasts. Int Immunol 1998;10:1421-1433.
28. Liu X, Conner H, Kobayashi T, et al. Synergetic effect of interleukin-4 and transforming growth factor-beta1 on type I collagen gel contraction and degradation by HFL-1 cells: implication in tissue remodelling. Chest 2003;123:427-428.
29. Fujitsua Y, Fukudaa K, Kumagaia BN, et al. IL-4-induced cell proliferation and production of extracellular matrix proteins in human conjunctival fibroblasts. Exp Eye Res 2003;76:107-114.
30. Ando M, Miyazaki E, Fukami T, et al. Interleukin-4-producing cells in idiopathic pulmonary fibrosis: an immunohistochemical study. Respirology 1999;4:383-391.
31. Salmon-Ehr V, Serpier H, Nawrocki B, et al. Expression of interleukin-4 in scleroderma skin specimens and scleroderma fibroblast cultures. Potential role in fibrosis. Arch Dermatol 1996;132:802-806.
32. Tiggelman AM, Boers W, Linthorst C, et al. Collagen synthesis by human liver (myo)fibroblasts in culture: evidence for a regulatory role of IL-1 beta, IL-4, TGFβ and IFN gamma. J Hepatol 1995;23:307-317.
33. Sugimoto R, Enjoji M, Nakamuta M, et al. Effect of IL-4 and IL-13 on collagen production in cultured LI90 human hepatic stellate cells. Liver Int 2005;25:420-428.
34. Farah IO, Mola PW, Kariuki TM, et al. Repeated exposure induces periportal fibrosis in Schistosoma mansoni-infected baboons: role of TGF-beta and IL-4. J Immunol 2000;164:5337-5343.
35. Cheever AW, Williams ME, Wynn TA, et al. Anti-lL-4 treatment of Schistosoma mansoni-infected mice inhibits development of T cells and non-B, non-T cells expressing Th2 cytokines while decreasing egg-induced hepatic fibrosis. J Immunol 1994;153:753-759.
36. Hillaire S, Boucher E, Calmus Y, et al. Effects of bile acids and cholestasis on major histocompatibility complex class I in human and rat hepatocytes. Gastroenterology 1994;107:781-788.
37. Win KM, Charlotte F, Mallat A, et al. Mitogenic effect of transforming growth factor-beta 1 on human Ito cells in culture: evidence for mediation by endogenous platelet-derived growth factor. Hepatology 1993;18:137-145.
38. Conti F, Frappier J, Dharancy S, et al. Interleukin-15 production during liver allograft rejection in humans. Transplantation 2003;76:210-216.
39. Sohara N, Znoyko I, Levy MT, et al. Reversal of activation of human myofibroblast-like cells by culture on a basement membrane-like substrate. J Hepatol 2002;37:214-221.
40. Davaille J, Li L, Mallat A, et al. Sphingosine 1-phosphate triggers both apoptotic and survival signals for human hepatic myofibroblasts. J Biol Chem 2002;277:37323-37330.
41. Van der Velden VHJ, Naber BAE, Wierenga-Wolf AF, et al. Interleukin-4 receptors on human bronchial epithelial cells. An in vivo and vitro analysis of expression and function. Cytokine 1998;10:803-813.
42. De Leeuw WJ, Slagboom PE, Vijg J. Quantitative comparison of mRNA levels in mammalian tissues: 28 s ribosomal RNA level as an accurate internal control. Nucleic Acids Res 1989;23:10137-10138.
43. Razzaque MS, Ahmed BS, Foster S, et al. Effects of IL-4 on conjunctival fibroblasts: possible role in ocular cicatricial pemphigoid. Invest Ophthalmol Vis Sci 2003;44:3417-3423.
44. Harumiya S, Gibson MA, Koshira Y. Antisense suppression of collagen VI synthesis results in reduced expression of collagen I in normal human osteoblast-like cells. Biosci Biotechnol Biochem 2002;66:2743-2747.
45. Lam S, Van der Geest RN, Verhagen NA, et al. Secretion of collagen type IV by human renal fibroblasts is increased by high glucose via a TGF-beta-independent pathway. Nephrol Dial Transplant 2004;19:1694-1701.
46. Sugiyama S, Kugiyama K, Nakamura S, et al. Characterization of smooth muscle-like cells in circulating human peripheral blood. Atherosclerosis 2006;187:351-362.
47. Dondi E, Rogge L, Lutfalla G, et al. Down-modulation of responses to type I IFN upon T cell activation. J Immunol 2003;170:749-756.
48. Zhang MS, Zhou YF, Zhang WJ, et al. Apoptosis induced by short hairpin RNA-mediated STAT6 gene silencing in human colon cancer cells. Chin Med J 2006;119:801-808.
49. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta (CT)) method. Methods 2001;25:402-408.
50. Knittel T, Kobold D, Piscaglia F, et al. Localization of liver myofibroblasts and hepatic stellate cells in normal and diseased rat livers: distinct roles of (myo-)fibroblast subpopulations in hepatic tissue repair. Histochem Cell Bio 1999;112:387-401.
51. Koenig S, Krause P, Drabent B, et al. The expression of mesenchymal, neural and haematopoietic stem cell markers in adult hepatocytes proliferating in vitro. J Hepatol 2006;44:1115-1124.
52. Saalbach A, Kraft R, Herrmann K, et al. The monoclonal antibody AS02 recognizes a protein on human fibroblasts being highly homologous to Thy-1. Arch Dermatol Res 1998;290:360-366.
53. Tang L, Luo QL, Xia QJ, et al. The study of CD90 expressing in orbital fibroblasts of thyroid associated ophthalmopathy. Sichuan Da Xue Xue Bao Yi Xue Ban 2006;37:37879-37881.
54. Raposio E, Guida C, Baldelli I, et al. Characterization and induction of human pre-adipocytes. Toxicol In Vitro 2007;21:330-334.
55. Berenguer M. Natural history of recurrent hepatitis C. Liver Transpl 2002;8:14-18.
56. Neumann UP, Berg T, Bahra M, et al. Fibrosis progression after liver transplantation in patients with recurrent hepatitis C. J Hepatol 2004;41:830-836.
57. Aoudjehane L, Podevin P, Scatton O, et al. Interleukin-4 induces human hepatocyte apoptosis through a Fas-independent pathway. FASEB J 2007;21:1433-1444.
58. Gallois C, Habib A, Tao J, et al. Role of NF-kappaB in the antiproliferative effect of endothelin-1 and tumor necrosis factor-alpha in human hepatic stellate cells. Involvement of cyclooxygenase-2. J Biol Chem 1998;273:23183-23190.
59. Gressner AM, Lahme B, Meurer SK, et al. Variable expression of cystatin C in cultured trans-differentiating rat hepatic stellate cells. World J Gastroenterol 2006;12:731-738.
60. Guyot C, Lepreux S, Combe C, et al. Hepatic fibrosis and cirrhosis. The (myo)fibroblastic cell subpopulations involved. Int J Biochem Cell Biol 2006;38:135-151.
61. Jaruga B, Hong F, Sun R. Crucial role of IL4/STAT6 in T cell-mediated hepatitis: up-regulation eotaxin and IL5 and recruiting leukocytes. J Immunol 2003;171:3233-3244.
62. Ethier MF, Madison JM. IL-4 inhibits calcium transients in bovine rachealis cells by a ryanodine receptor dependent mechanism. FASEB J 2005;20:154-156.
63. Li B, Sun R, Wei H, et al. Interleukin-15 prevents concanavalin A-induced liver injury in mice via NKT cell-dependent mechanism. Hepatology 2006;43:1211-1219.
64. Rodrigues DB, Correia D, Marra MD, et al. Cytokine serum levels in patients infected by human immunodeficiency virus with and without Trypanosoma cruzi coinfection. Rev Soc Bras Med Trop 2005;38:483-487.
65. Sasaki Y, Mita H, Toyota M, et al. Identification of the interleukin 4 receptor alpha gene as a direct target for p73. Cancer Res 2003;63:8145-8152.
66. Wurster AL, Tanaka T, Grusby MJ. The biology of Stat4 and Stat6. Oncogene 2000;19:2577-2584.
67. Jiang H, Harris MB, Rothman P. IL-4/IL-13 signaling beyond JAK/STAT. J Allergy Clin Immunology 2000;105:1063-1070.
68. McGaha TL, Le M, Kodera T, et al. Molecular mechanisms of interleukin-4-induced up-regulation of type I collagen gene expression in murine fibroblasts. Arthritis Rheum 2003;48:2275-2284.
69. Buttner C, Skupin A, Riebe EP. Transcriptional activation of the type I collagen genes COL1A1 and COL1A2 in fibroblasts by interleukin-4: analysis of the functional collagen promoter sequences. J Cell Physiol 2004;198:248-258.